UroGen Pharma Ltd.

URGN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$171,987$95,002$55,408$44,360
Short-Term Investments$64,698$41,966$44,556$44,779
Receivables$20,302$15,443$12,704$11,717
Inventory$9,227$5,673$4,325$4,832
Other Curr. Assets$9,921$11,102$11,914$8,702
Total Curr. Assets$276,135$169,186$128,907$114,390
Property Plant & Equip (Net)$3,789$2,360$3,749$3,147
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$5,022$4,502$0$675
Tax Assets$0$0$0$0
Other NC Assets$765$2,263$2,963$1,534
Total NC Assets$9,576$9,125$6,712$5,356
Other Assets$0$0$0$0
Total Assets$285,711$178,311$135,619$119,746
Liabilities
Payables$10,931$6,514$5,527$5,786
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$35,018$24,698$18,389$16,594
Total Curr. Liab.$45,949$31,212$23,916$22,380
LT Debt$123,387$99,395$99,123$398
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$3,018$2,842
Other NC Liab.$125,178$112,916$98,923$85,713
Total NC Liab.$248,565$212,311$201,064$88,953
Other Liabilities$0$0$0$0
Cap. Leases$1,653$844$1,586$398
Total Liabilities$294,514$243,523$224,980$111,333
Equity
Pref Stock$0$0$0$0
Common Stock$115$89$63$61
Retained Earnings-$806,222-$679,348-$577,104-$467,321
AOCI$56$12-$107-$25
Other Equity$797,248$614,035$487,787$475,698
Total Equity-$8,803-$65,212-$89,361$8,413
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$285,711$178,311$135,619$119,746
Net Debt-$48,600$4,393$43,715-$43,962
UroGen Pharma Ltd. (URGN) Financial Statements & Key Stats | AlphaPilot